Nagendra K Chaturvedi

11PUBLICATIONS
18CO-AUTHORS
Medical infection agents (incl. prions)Neurology and neuromuscular diseasesMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 13, 2026
Development and Validation of an LC-MS/MS Method for the Quantitation of JNJ-64619178 (JNJ) in Mouse Plasma: Characterization of In Vitro and In Vivo Pharmacokinetic Properties.

|Jun 18, 2024
The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma.

Anup S Pathania, Haritha Chava, Nagendra K Chaturvedi

|Jan 10, 2024
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma.

Don W Coulter, Yashpal S Chhonker, Devendra Kumar

|Dec 23, 2023
PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma.

Devendra Kumar, Stuti Jain, Don W Coulter

|Jul 20, 2023
EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis.

Sukanya Chakraborty, Aaqib M Bhat, Insha Mushtaq

|May 16, 2023
STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo.

Kyle A Rohrer, Heyu Song, Anum Akbar

Pageof 2

Frequent Collaborators

2 joint publications

Hamid Band

2 joint publications

Don W Coulter

1 joint publications

Jose Antonio Lopez-Guerrero

1 joint publications

Katia Scotlandi